Cutler Group LP Seagen Inc. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 07, 2023	SELL	$191.51 - $216.16 $287,265 - $324,240	-1,500 Reduced 7.69%	18,000 $45,000
Q2 2023 Jul 18, 2023	BUY	$187.64 - $206.25 $3.66 Million - $4.02 Million	19,500 New	19,500 $84,000
Q3 2022 Oct 25, 2022	SELL	$135.27 - $180.11 $500,499 - $666,407	-3,700 Reduced 59.68%	2,500 $45,000
Q2 2022 Aug 04, 2022	BUY	$108.81 - $179.33 $544,050 - $896,650	5,000 Added 416.67%	6,200 $35,000
Q1 2022 Apr 14, 2022	BUY	$119.61 - $157.85 $143,532 - $189,420	1,200 New	1,200 $0

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.